Cargando…

ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh

PURPOSE: The world is heavily suffering from the COVID-19 pandemic for more than a year, with over 191 million confirmed cases and more than 4.1 million deaths to date. Previous studies have explored several risk factors for coronavirus disease 2019 (COVID-19), but there is still a lack of associati...

Descripción completa

Detalles Bibliográficos
Autores principales: Halim, Mohammad Rabiul, Saha, Shuvajit, Haque, Injamam Ull, Jesmin, Sadia, Nishat, Rahatul Jannat, Islam, A S M D Ashraful, Roy, Seema, Haque, Miah Md Akiful, Islam, Md Motiul, Hamid, Tarikul, Ahmed, Kazi Nuruddin, Talukder, Md Azharul Islam, Ahmed, Arif, Hasan, Emran, Ananna, Nurjahan, Mohsin, Faroque Md, Hawlader, Mohammad Delwer Hossain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421326/
https://www.ncbi.nlm.nih.gov/pubmed/34511926
http://dx.doi.org/10.2147/JMDH.S330958
_version_ 1783749057699643392
author Halim, Mohammad Rabiul
Saha, Shuvajit
Haque, Injamam Ull
Jesmin, Sadia
Nishat, Rahatul Jannat
Islam, A S M D Ashraful
Roy, Seema
Haque, Miah Md Akiful
Islam, Md Motiul
Hamid, Tarikul
Ahmed, Kazi Nuruddin
Talukder, Md Azharul Islam
Ahmed, Arif
Hasan, Emran
Ananna, Nurjahan
Mohsin, Faroque Md
Hawlader, Mohammad Delwer Hossain
author_facet Halim, Mohammad Rabiul
Saha, Shuvajit
Haque, Injamam Ull
Jesmin, Sadia
Nishat, Rahatul Jannat
Islam, A S M D Ashraful
Roy, Seema
Haque, Miah Md Akiful
Islam, Md Motiul
Hamid, Tarikul
Ahmed, Kazi Nuruddin
Talukder, Md Azharul Islam
Ahmed, Arif
Hasan, Emran
Ananna, Nurjahan
Mohsin, Faroque Md
Hawlader, Mohammad Delwer Hossain
author_sort Halim, Mohammad Rabiul
collection PubMed
description PURPOSE: The world is heavily suffering from the COVID-19 pandemic for more than a year, with over 191 million confirmed cases and more than 4.1 million deaths to date. Previous studies have explored several risk factors for coronavirus disease 2019 (COVID-19), but there is still a lack of association with ABO blood type. This study aimed to find out the relationship between the ABO blood group and COVID-19 outcomes in Bangladesh. SUBJECTS AND METHODS: This retrospective cross-sectional study was conducted in the intensive care unit (ICU) of a tertiary-level COVID-dedicated hospital in Dhaka city, Bangladesh, between April 2020 and November 2020. Records from 771 critically ill patients were extracted who were confirmed for COVID-19 by reverse transcriptase-polymerase chain reaction (RT-PCR) assay, and blood grouping records were available in the health records. RESULTS: The blood groups were 37.35%, 17.38%, 26.46%, and 18.81% for A, B, AB, and O type, respectively. Clinical symptoms were significantly more common in patients with blood type A (p < 0.05). Patients with blood type A had higher WBC counts and peak serum ferritin levels and both were statistically significant (p < 0.001). Patients with blood type A had a greater need for supplemental oxygen, and they were more likely to die in comparison to the patients with other blood types (p < 0.05). In multivariable analysis, our primary outcome death was significantly associated with blood type A (AOR: 3.49, 95% CI: 1.57–7.73) while adjusting for age, male gender, and non-communicable diseases. CONCLUSION: Based on this study results, it can be concluded that the COVID-19 patients with blood type A have a higher chance of death and other complications. The authors recommend blood grouping before treating the COVID-19 patients, and healthcare workers should prioritize treating the patients based on that result.
format Online
Article
Text
id pubmed-8421326
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84213262021-09-09 ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh Halim, Mohammad Rabiul Saha, Shuvajit Haque, Injamam Ull Jesmin, Sadia Nishat, Rahatul Jannat Islam, A S M D Ashraful Roy, Seema Haque, Miah Md Akiful Islam, Md Motiul Hamid, Tarikul Ahmed, Kazi Nuruddin Talukder, Md Azharul Islam Ahmed, Arif Hasan, Emran Ananna, Nurjahan Mohsin, Faroque Md Hawlader, Mohammad Delwer Hossain J Multidiscip Healthc Original Research PURPOSE: The world is heavily suffering from the COVID-19 pandemic for more than a year, with over 191 million confirmed cases and more than 4.1 million deaths to date. Previous studies have explored several risk factors for coronavirus disease 2019 (COVID-19), but there is still a lack of association with ABO blood type. This study aimed to find out the relationship between the ABO blood group and COVID-19 outcomes in Bangladesh. SUBJECTS AND METHODS: This retrospective cross-sectional study was conducted in the intensive care unit (ICU) of a tertiary-level COVID-dedicated hospital in Dhaka city, Bangladesh, between April 2020 and November 2020. Records from 771 critically ill patients were extracted who were confirmed for COVID-19 by reverse transcriptase-polymerase chain reaction (RT-PCR) assay, and blood grouping records were available in the health records. RESULTS: The blood groups were 37.35%, 17.38%, 26.46%, and 18.81% for A, B, AB, and O type, respectively. Clinical symptoms were significantly more common in patients with blood type A (p < 0.05). Patients with blood type A had higher WBC counts and peak serum ferritin levels and both were statistically significant (p < 0.001). Patients with blood type A had a greater need for supplemental oxygen, and they were more likely to die in comparison to the patients with other blood types (p < 0.05). In multivariable analysis, our primary outcome death was significantly associated with blood type A (AOR: 3.49, 95% CI: 1.57–7.73) while adjusting for age, male gender, and non-communicable diseases. CONCLUSION: Based on this study results, it can be concluded that the COVID-19 patients with blood type A have a higher chance of death and other complications. The authors recommend blood grouping before treating the COVID-19 patients, and healthcare workers should prioritize treating the patients based on that result. Dove 2021-09-02 /pmc/articles/PMC8421326/ /pubmed/34511926 http://dx.doi.org/10.2147/JMDH.S330958 Text en © 2021 Halim et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Halim, Mohammad Rabiul
Saha, Shuvajit
Haque, Injamam Ull
Jesmin, Sadia
Nishat, Rahatul Jannat
Islam, A S M D Ashraful
Roy, Seema
Haque, Miah Md Akiful
Islam, Md Motiul
Hamid, Tarikul
Ahmed, Kazi Nuruddin
Talukder, Md Azharul Islam
Ahmed, Arif
Hasan, Emran
Ananna, Nurjahan
Mohsin, Faroque Md
Hawlader, Mohammad Delwer Hossain
ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh
title ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh
title_full ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh
title_fullStr ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh
title_full_unstemmed ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh
title_short ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh
title_sort abo blood group and outcomes in patients with covid-19 admitted in the intensive care unit (icu): a retrospective study in a tertiary-level hospital in bangladesh
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421326/
https://www.ncbi.nlm.nih.gov/pubmed/34511926
http://dx.doi.org/10.2147/JMDH.S330958
work_keys_str_mv AT halimmohammadrabiul abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT sahashuvajit abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT haqueinjamamull abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT jesminsadia abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT nishatrahatuljannat abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT islamasmdashraful abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT royseema abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT haquemiahmdakiful abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT islammdmotiul abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT hamidtarikul abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT ahmedkazinuruddin abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT talukdermdazharulislam abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT ahmedarif abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT hasanemran abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT anannanurjahan abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT mohsinfaroquemd abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh
AT hawladermohammaddelwerhossain abobloodgroupandoutcomesinpatientswithcovid19admittedintheintensivecareuniticuaretrospectivestudyinatertiarylevelhospitalinbangladesh